| 2 | 1/1 | 返回列表 |
| 查看: 700 | 回復: 1 | |||
[交流]
【求助】求助幾個藥品的國外質(zhì)量標準
|
|
求助幾個藥品的國外質(zhì)量標準 pramipexole,moxifloxacin,imatinib,sitafloxacin,linezolid 求助以上藥品的國外質(zhì)量標準,如USP,EP,JP,UK. 謝謝! |
» 搶金幣啦!回帖就可以得到:
+2/102
+1/85
+1/82
+1/42
+2/40
+1/39
+1/39
+1/16
+1/7
+1/7
+1/6
+1/6
+1/4
+1/4
+1/3
+1/2
+1/2
+1/1
+1/1
+1/1
|
Moxifloxacin Hydrochloride (mox'' i flox' a sin hye'' droe klor' ide) C21H24FN3O4·HCl 437.89 (4aS-cis)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride [186826-86-8]. DEFINITION Moxifloxacin Hydrochloride contains NLT 98.0% and NMT 102.0% of C21H24FN3O4·HCl, calculated on the anhydrous basis. IDENTIFICATION • A. Infrared Absorption 197K • B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. • C. Identification Tests—General, Chloride 191: Meets the requirements Sample solution: To a solution (1 in 160) add diluted nitric acid, and filter. ASSAY • Procedure Buffer: Dissolve 0.5 g of tetrabutylammonium hydrogen sulfate and 1.0 g of monobasic potassium phosphate in water, add 2 mL of phosphoric acid, dilute with water to 1000 mL, mix, and pass through a 0.45-µm filter. Mobile phase: Methanol and Buffer (7:18) Diluent: Add 20 mg of anhydrous sodium sulfite to 1000 mL of Buffer solution, mix gently, and pass through a 0.45-µm filter. System suitability solution: 0.1 and 0.001 mg/mL of USP Moxifloxacin Hydrochloride RS and USP Moxifloxacin Related Compound A RS, respectively, in Diluent Standard solution: 0.1 mg/mL of USP Moxifloxacin Hydrochloride RS in Diluent Sample solution: 0.1 mg/mL of moxifloxacin hydrochloride in Diluent Chromatographic system (See Chromatography 621, System Suitability.) Mode: LC Detector: UV 293 nm Column: 4.0-mm × 25-cm; 5-µm packing L11 Flow rate: 0.9 mL/min Temperature: 45 Injection size: 25 µL System suitability Samples: System suitability solution and the Standard solution [Note—The relative retention times are about 1.0 and 1.2, respectively. ] Suitability requirements Resolution: NLT 1.5 between moxifloxacin and moxifloxacin related compound A, System suitability solution Column efficiency: NLT 4000 theoretical plates, Standard solution Tailing factor: NMT 2.0, Standard solution Relative standard deviation: NMT 2.0%, Standard solution Analysis Samples: Standard solution and Sample solution Calculate the percentage of C21H24FN3O4·HCl in the portion of moxifloxacin hydrochloride taken: Result = (rU/rS) × (CS/CU) × 100 rU = = peak response from the Sample solution rS = = peak response from the Standard solution CS = = concentration of USP Moxifloxacin Hydrochloride RS in the Standard solution (mg/mL) CU = = nominal concentration of moxifloxacin hydrochloride in the Sample solution (mg/mL) Acceptance criteria: 98.0%–102.0% on the anydrous basis IMPURITIES Inorganic Impurities • Residue on Ignition 281: NMT 0.1% • Chloride and Sulfate, Sulfate 221 Analysis: 0.6 g shows no more sulfate than corresponds to 0.25 mL of 0.020 N sulfuric acid. Acceptance criteria: NMT 0.04% Organic Impurities • Procedure: [Note—Protect solutions from light. ] Mobile phase and Diluent: Prepare as directed in the Assay. Blank solution: Use the Diluent. System suitability solution: Prepare as directed in the Assay. Sensitivity solution: 0.05 µg/mL of USP Moxifloxacin Hydrochloride RS from the Standard solution in Diluent [Note—Store the Sensitivity solution under refrigeration and protected from light. ] Standard solution: 2 µg/mL of USP Moxifloxacin Hydrochloride RS in Diluent Sample solution: Prepare as directed in the Assay. Chromatographic system: Proceed as directed in the Assay. System suitability Samples: System suitability solution, Sensitivity solution, and Standard solution Suitability requirements Resolution: NLT 1.5 between moxifloxacin and moxifloxacin related compound A, System suitability solution Column efficiency: NLT 4000 theoretical plates, Standard solution Tailing factor: NMT 2.0, Standard solution Relative standard deviation: NMT 2.0%, Standard solution Signal-to-noise ratio: NLT 10, Sensitivity solution Analysis Samples: Blank solution, Standard solution, and Sample solution Calculate the percentage of each impurity in the portion of moxifloxacin hydrochloride taken: Result = (rU/rS) × (CS/CU) × (1/F) × 100 rU = = peak response of each impurity from the Sample solution rS = = peak response of moxifloxacin hydrochloride from the Standard solution CS = = concentration of USP Moxifloxacin Hydrochloride RS in the Standard solution (mg/mL) CU = = nominal concentration of moxifloxacin hydrochloride in the Sample solution (mg/mL) F = = relative response factor (see Impurity Table 1) Acceptance criteria Individual impurities: See Impurity Table 1. Total impurities: NMT 1.0% Impurity Table 1 Name Relative Retention Time Relative Response Factor Acceptance Criteria, NMT % Moxifloxacin related compound Aa 1.15 1.0 0.1 6,8-Dimethoxyb 1.32 0.71 0.1 8-Ethoxyc 1.48 1.0 0.1 6-Methoxy-8-fluorod 1.71 1.0 0.1 8-Hydroxye 1.83 0.29 0.1 Other individual impurity — 1.0 0.1 Total impurities — — 0.5 a 1-Cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. b 1-Cyclopropyl-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. c 1-Cyclopropyl-8-ethoxy-6-fluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. d 1-Cyclopropyl-8-fluoro-6-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. e 1-Cyclopropyl-6-fluoro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. SPECIFIC TESTS • Optical rotation, Specific rotation 781S Sample: 10 mg/mL in acetonitrile and water (1:1) Acceptance criteria: 125 to 138 at 20 • Microbial Enumeration Tests 61 and Tests for Specified Microorganisms 62: Total aerobic microbial count: NMT 1000 cfu/g Total combined molds and yeasts count: NMT 100 cfu/g • pH 791: Sample solution: 0.2 in 100 Acceptance criteria: 3.9–4.6 • Water Determination Method Ia 921: NMT 4.5% ADDITIONAL REQUIREMENTS • Packaging and Storage: Preserve in tight, light-resistant containers. Store at room temperature. • USP Reference Standards 11 USP Moxifloxacin Hydrochloride RS USP Moxifloxacin Related Compound A RS Auxiliary Information— Please check for your question in the FAQs before contacting USP. Topic/Question Contact Expert Committee Monograph Behnam Davani, Ph.D., M.B.A. Senior Scientist 1-301-816-8394 (MDAA05) Monograph Development-Antivirals and Antimicrobials 61 Radhakrishna S Tirumalai, Ph.D. Senior Scientific Liaison 1-301-816-8339 (MSA05) Microbiology and Sterility Assurance 62 Radhakrishna S Tirumalai, Ph.D. Senior Scientific Liaison 1-301-816-8339 (MSA05) Microbiology and Sterility Assurance Reference Standards Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org USP33–NF28 Page 3929 Pharmacopeial Forum: Volume No. 34(5) Page 1170 Chromatographic Column— MOXIFLOXACIN HYDROCHLORIDE Chromatographic columns text is not derived from, and not part of, USP 33 or NF 28. |
| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 0856求調(diào)劑 +5 | 楒桉 2026-03-28 | 5/250 |
|
|---|---|---|---|---|
|
[考研] 305求調(diào)劑 +6 | RuiFairyrui 2026-03-28 | 6/300 |
|
|
[考研] 一志愿北京理工大學本科211材料工程294求調(diào)劑 +4 | mikasa的圍巾 2026-03-28 | 4/200 |
|
|
[考研] 調(diào)劑310 +6 | 溫柔的晚安 2026-03-25 | 7/350 |
|
|
[考研] 283求調(diào)劑 +7 | A child 2026-03-28 | 7/350 |
|
|
[考研] 0856,材料與化工321分求調(diào)劑 +12 | 大饞小子 2026-03-27 | 13/650 |
|
|
[考研] 求調(diào)劑推薦 材料 304 +15 | 荷包蛋hyj 2026-03-26 | 15/750 |
|
|
[考研] 315分求調(diào)劑 +7 | 26考研上岸版26 2026-03-26 | 7/350 |
|
|
[考研] 化學調(diào)劑 +4 | 愛吃番茄的旭 2026-03-24 | 5/250 |
|
|
[考研] 材料292調(diào)劑 +12 | 橘頌思美人 2026-03-23 | 12/600 |
|
|
[考研] 279 分 求調(diào)劑 +4 | 睡個好覺_16 2026-03-24 | 4/200 |
|
|
[考研] 276求調(diào)劑。有半年電池和半年高分子實習經(jīng)歷 +10 | 材料學257求調(diào)劑 2026-03-23 | 11/550 |
|
|
[考研] 359求調(diào)劑 +4 | 王了個楠 2026-03-25 | 4/200 |
|
|
[考研] 材料調(diào)劑 +8 | 匹克i 2026-03-23 | 8/400 |
|
|
[考研] 284求調(diào)劑 +11 | junqihahaha 2026-03-26 | 12/600 |
|
|
[考研] 352求調(diào)劑 +4 | 大米飯! 2026-03-22 | 4/200 |
|
|
[考研] 生物技術(shù)與工程 +3 | 1294608413 2026-03-25 | 4/200 |
|
|
[考研] 086003食品工程求調(diào)劑 +6 | 淼淼111 2026-03-24 | 6/300 |
|
|
[考研] 一志愿北化315 求調(diào)劑 +3 | akrrain 2026-03-24 | 3/150 |
|
|
[考研] 335求調(diào)劑 +4 | yuyu宇 2026-03-23 | 5/250 |
|